MyCare - Patients: View your medical records securely online here.
Log in Learn More

Multi-center validation of prediction scores for contrast-induced nephropathy after percutaneous coronary intervention. Funded by grant from the National Kidney Foundation of Upstate New York

Description: Radiocontrast dyes are compounds used for procedures such as percutaneous coronary intervention (PCI) in which dye is injected into the blood vessels of the heart to image any narrowed vessels. However, these dyes are toxic to the kidney and may lead to renal failure. The average risk of developing kidney damage in such a setting is approximately 1 in 6, but is higher in patients with diabetes, previous kidney disease or heart failure. Development of such kidney damage can lead to substantial increase in illness or even death. This project is designed to help identify patients who are at increased risk of kidney damage after PCI. We propose to validate the existing risk scoring systems to determine their accuracy in multiple settings. Early identification of at-risk patients will enable doctors to take appropriate measures to reduce the risk of kidney damage.
IRB Number: 1044A
Status: Enrollment Complete
Start Date: August 01, 2009
Principal Name: Sagar U. Nigwekar, MD
Contact Name: Sagar U. Nigwekar, MD
Phone: (585) 922-4101